Medicare Enrolled

Dr. Sayed Aamir, M.D.

Endocrinology · Snellville, GA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1800 TREE LN STE 190, Snellville, GA 30078
7705458435
In practice since 2007 (19 years)
NPI: 1083745863 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Aamir from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Aamir? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Aamir

Dr. Sayed Aamir is an endocrinology specialist in Snellville, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Aamir performed 887 Medicare services across 578 unique beneficiaries.

Between the years covered by Open Payments, Dr. Aamir received a total of $9,048 from 55 pharmaceutical and/or device companies across 548 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Aamir is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 887 Medicare services $9,048 industry payments

Medicare Practice Summary

Medicare Utilization ↗
887
Medicare services
Bottom 47% in GA for endocrinology
578
Unique beneficiaries
$64
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~47 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
365 $79 $325
Obesity behavioral counseling, 15 minutes
A 15-minute face-to-face session focused on behavioral counseling to help manage obesity.
113 $24 $50
Autonomic nervous system function test
This test evaluates how well the sympathetic nervous system is functioning. It assesses the automatic control of bodily processes such as heart rate and blood pressure.
94 $88 $277
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
92 $24 $80
Ultrasound of head and neck soft tissue
This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation.
71 $77 $325
Ultrasound of arm and leg arteries
A non-invasive imaging test that uses sound waves to examine the blood vessels in the arms and legs. It evaluates blood flow and checks for blockages or other vascular issues.
50 $78 $325
Ultrasound of arm and leg arteries
This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries.
46 $57 $300
Autonomic nervous system testing with heart rate response to deep breathing
This test evaluates the function of the autonomic nervous system by measuring how the heart rate changes in response to deep breathing.
41 $63 $300
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
15 $44 $250
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$9,048
Total received (2018-2024)
Avg $1,293/year across 7 years
Top 28% in GA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
55
Companies
548
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,048 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,424
2023
$1,455
2022
$1,338
2021
$885
2020
$452
2019
$1,787
2018
$1,708

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$269
Abbott Laboratories
$219
Lilly USA, LLC
$138
VIVUS LLC
$96
Amgen Inc.
$96
BETA BIONICS, INC.
$79
Xeris Pharmaceuticals, Inc.
$72
Bayer Healthcare Pharmaceuticals Inc.
$71
ABBVIE INC.
$60
SANOFI-AVENTIS U.S. LLC
$55
Corcept Therapeutics
$55
CeQur Corporation
$29
Esperion Therapeutics, Inc.
$28
Radius Health, Inc.
$26
Mannkind Corporation
$22
Amneal Pharmaceuticals LLC
$20
Ascensia Diabetes Care Us Inc.
$20
Dexcom, Inc.
$20
Amphastar Pharmaceuticals, Inc.
$16
IBSA Pharma Inc.
$15
Boehringer Ingelheim Pharmaceuticals, Inc.
$15
Top 3 companies account for 44.0% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$1,778
Lilly USA, LLC
$963
AstraZeneca Pharmaceuticals LP
$371
Insulet Corporation
$366
Abbott Laboratories
$326
VIVUS LLC
$321
Amgen Inc.
$310
Mannkind Corporation
$303
Boehringer Ingelheim Pharmaceuticals, Inc.
$292
SANOFI-AVENTIS U.S. LLC
$276
IBSA Pharma Inc.
$253
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$241
Xeris Pharmaceuticals, Inc.
$239
Bayer Healthcare Pharmaceuticals Inc.
$183
Valeritas, Inc.
$175
Medtronic MiniMed, Inc.
$157
Shire North American Group Inc
$147
Merck Sharp & Dohme Corporation
$142
Amarin Pharma Inc.
$138
Corcept Therapeutics
$126
Janssen Pharmaceuticals, Inc
$123
Tandem Diabetes Care, Inc.
$122
CeQur Corporation
$116
Currax Pharmaceuticals LLC
$111
Esperion Therapeutics, Inc.
$111
Amneal Pharmaceuticals LLC
$110
Becton, Dickinson and Company
$86
VIVUS, Inc.
$85
BETA BIONICS, INC.
$79
ABBVIE INC.
$73
Merck Sharp & Dohme LLC
$69
Antares Pharma, Inc.
$67
Nalpropion Pharmaceuticals LLC
$63
Dexcom, Inc.
$63
Senseonics, Incorporated
$62
Alexion Pharmaceuticals, Inc.
$61
TOPCON HEALTHCARE SOLUTIONS, INC.
$53
Horizon Therapeutics plc
$48
AbbVie Inc.
$46
Medtronic, Inc.
$43
AbbVie, Inc.
$42
MannKind Corporation
$35
Alfasigma USA, Inc.
$32
Ultragenyx Pharmaceutical Inc.
$29
Radius Health, Inc.
$26
Orexigen Therapeutics, Inc.
$25
Embecta Corp.
$24
Ascensia Diabetes Care Us Inc.
$20
Endo Pharmaceuticals Inc.
$20
Aegerion Pharmaceuticals, Inc.
$19
ASSERTIO THERAPEUTICS, Inc.
$18
Bayer HealthCare Pharmaceuticals Inc.
$17
Amphastar Pharmaceuticals, Inc.
$16
LifeScan, Inc.
$12
Nalpropion Pharmaceuticals, Inc.
$11
Top 3 companies account for 34.4% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Androgel · BAQSIMI · BD 6cess · BD NANO · BD Nano · BD Nano 2nd Gen Pen Needle · CONTRAVE · CRYSVITA · CYCLOSET · CeQur Simplicity · Crysvita · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · Dexcom G6 Transmitter · EVENITY · EVERSENSE 365 SENSOR KIT (RETAIL) · Eversense · FARXIGA · FIASP · FORTEO · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · Gralise · HARMONY · HUMULIN · HUMULIN R 500 · INVOKANA · InPen · JANUVIA · JARDIANCE · Kerendia · Korlym · LICART · LINZESS · LYUMJEV · MINIMED 780G · MOUNJARO · MYALEPT · Minimed 670G System · NASCOBAL · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · OTREXUP · Omnipod · OneTouch · Otrexup · Ozempic · Pancreaze · Prolia · QSYMIA · Qsymia · RECORLEV · RYBELSUS · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · STRENSIQ · SYNJARDY · SYNTHROID · Saxenda · Strensiq · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tymlos · UNITHROID · V-GO · Vascepa · Victoza · Wegovy · XARELTO · Xultophy 100/3.6 · ZEPBOUND · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an endocrinology specialist in Snellville?
Compare endocrinologists in the Snellville area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
88
Per 100K population
9.1
County median income
$84,823
Nearest hospital
PIEDMONT EASTSIDE MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Aamir is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Aamir experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Aamir performed 365 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Aamir receive payments from pharmaceutical companies?
Yes. Dr. Aamir received a total of $9,048 from 55 companies across 548 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Aamir's costs compare to other endocrinologists in Snellville?
Dr. Aamir's average Medicare payment per service is $64. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Aamir) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →